IG Key Stats
- IGI LABORATORIES, INC Files SEC form 10-Q, Quarterly Report May 15
- IGI Laboratories' CEO Discusses Q1 2013 Results - Earnings Call Transcript Seeking Alpha Apr 25
- IGI Laboratories Inc Earnings Call scheduled for 4:30 pm ET today Apr 25
- IGI Laboratories Announces 1st Quarter 2013 Results Business Wire Apr 25
- IGI LABORATORIES, INC Files SEC form 8-K, Results of Operations and Financial Co... Apr 25
- Q1 2013 IGI Laboratories Inc Earnings Release - Time Not Supplied Apr 25
- IGI Laboratories to Hold Conference Call for 1st Quarter 2013 Results Business Wire Apr 11
- IGI Laboratories to Present at 12th Annual Needham & Company Annual Healthcare C... Apr 5
- IGI Laboratories announces 10th ANDA submission Apr 4
- IGI Laboratories, Inc. Announces Tenth ANDA Submission Business Wire Apr 4
IG Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). IGI is up 53.85% over the last year vs S&P 500 Total Return up 27.77%, Acasti Pharma up 11.79%, and Durata Therapeutics up 0.00%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for IG
Pro Report PDF for IG
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download IG Pro Report PDF
Pro Strategies Featuring IG
Did IGI make it into our Pro Portfolio Strategies?